Mount Sinai Reportedly Stops Accepting New Patients With Certain Public Insurance Plans August 27, 2026 William Newton, Editor-in-Chief 340B Report Views Mount Sinai Health System has reportedly stopped accepting certain new patients who have coverage through two public insurance plans. … Share this on: Read More »
3 Drugmakers Exempt States from Contract Pharmacy Policies August 27, 2026 Luke Zarzecki, National Correspondent 340B Report Views Alkermes and two other drugmakers recently updated their 340B contract pharmacy restriction policies. … Share this on: Read More »
GSK, Galderma, Eli Lilly Announce 340B Refunds August 27, 2026 Shannon Young, Managing Editor 340B Report Views GSK, Galderma and Eli Lilly announced refunds for covered entities in notices posted to HRSA's OPA website this month. … Share this on: Read More »
3 Drugmakers Update 340B Contract Pharmacy, In-House Data Policies August 25, 2026 Shannon Young, Managing Editor 340B Report Views Merck and two other drugmakers recently updated their 340B contract pharmacy restrictions and in-house pharmacy claims data requirements. … Share this on: Read More »
Drugmakers Face Monday Deadline for 340B Rebate Pilot Plans August 20, 2026 William Newton, Editor-in-Chief 340B Report Views Selected manufacturers have an Aug. 24 deadline to send their 340B rebate pilot plans to HRSA for approval. … Share this on: Read More »
U.S. Senate Finance Committee Dems’ Drug Pricing RFI Sparks 340B Comments August 20, 2026 Luke Zarzecki, National Correspondent 340B Report Views 340B stakeholders urged U.S. Senate Finance Committee Democrats to consider competing drug pricing policy priorities in response to an RFI. … Share this on: Read More »
AHA Urges CMS to Consider 340B When Implementing MDPNP, PhRMA Warns Against ‘Price Setting’ August 20, 2026 Shannon Young, Managing Editor 340B Report Views AHA urged CMS to “avoid unintended consequences” affecting the 340B program in public comments on the agency's plan to implement the Medicare Drug Price Negotiation Program. … Share this on: Read More »
Four Drugmakers Exempt New States From 340B Contract Pharmacy, In-House Claims Data Reqs. August 18, 2026 Shannon Young, Managing Editor 340B Report Views Biogen, GSK, Sobi and Amgen announced state exemptions from their 340B contract pharmacy and in-house pharmacy claims data restrictions. … Share this on: Read More »
Florida U.S. House Members Urge State to Preserve HIV Funding, 340B Eligibility August 18, 2026 Luke Zarzecki, National Correspondent 340B Report Views Florida congressional members are urging the state surgeon general to ensure HIV funding reaches community-based organizations. … Share this on: Read More »
Provider Groups Defend Efforts to Intervene in AbbVie 340B Patient Definition Case August 13, 2026 Luke Zarzecki, National Correspondent 340B Report Views Provider groups defended their request to join HRSA in its defense against drugmaker AbbVie's lawsuit challenging the 340B patient definition. … Share this on: Read More »
